gen malaria drug is here; could help fight rising resistance, says Novartis

A new malaria drug, Ganaplacide/Lumefantrine, shows over 97% cure rates in trials. This treatment is effective even where current medicines are failing. The drug targets parasite transmission, potentially reducing spread. Novartis plans regulatory su…